Viridian Therapeutics (VRDN) Q4 2025 Earnings

5NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.04
-0.8
-0.57
-0.34

Details

Expected EPS
-1.018721
Actual EPS
-0.34
Surprise EPS
0.68
Surprise Percent
+66.62%

Description

Viridian Therapeutics (VRDN) has reported earnings of -0.34 per share for Q4 2025.

0 Comments

Share your thoughts